Response by Lei et al to letter regarding article, "Modernized Classification of Cardiac Antiarrhythmic Drugs"

Response by Lei et al to letter regarding article, "Modernized Classification of Cardiac Antiarrhythmic Drugs"

書目詳細資料
Main Authors:	Lei, M, Wu, L, Terrar, D, Huang, C
格式:	Journal article
語言:	English
出版:	American Heart Association 2019

相似書籍

Letter to the editor regarding the article of Chen et al.
由: Mehmet Sami Islamoglu, et al.
出版: (2022-12-01)

Cardiac Arrhythmias and Antiarrhythmic Drugs: An Autophagic Perspective
由: Joanne J. A. van Bavel, et al.
出版: (2018-02-01)

Arrhythmia Models for Drug Research: Classification of Antiarrhythmic Drugs
由: Keitaro Hashimoto
出版: (2007-01-01)

Letter by Antoniades et al regarding article, "Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction".
由: Antoniades, C, et al.
出版: (2010)

Letter by Rider and Neubauer regarding article, "Cardiac remodeling in obesity".
由: Rider, O, et al.
出版: (2013)

Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
由: T. N. Lipnitsky, et al.
出版: (2007-12-01)

Antiarrhythmic medication classification based on pathogenetic cardiac arrhythmia mechanisms
由: T. N. Lipnitsky, et al.
出版: (2007-12-01)

Modernised classification of cardiac anti-arrhytmic drugs
由: Lei, M, et al.
出版: (2018)

Response by Peterzan et al to letter regarding article, “Cardiac energetics in patients with aortic stenosis and preserved versus reduced ejection fraction”
由: Peterzan, MA, et al.
出版: (2020)

Letter to the Editor Regarding Vaping Article
由: Rabbi Yehuda Spitz
出版: (2019-10-01)

Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs
由: Sutanto, H, et al.
出版: (2019)

A Letter to the Editor on the Article by Farnam et al
由: Anne Rutte, MSc, et al.
出版: (2015-06-01)

Interactions that matter: 10 Antiarrhythmic drugs
由: Aronson, J
出版: (1987)

Letter regarding article by Becker et al, "Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase".
由: Antoniades, C, et al.
出版: (2005)

Letter to the Editor regarding Cunningham et al. 2020
出版: (2021-04-01)

Effects of Antiarrhythmic Drugs on Apoptotic Pathways in H9c2 Cardiac Cells
由: Shojiro Isomoto, et al.
出版: (2006-01-01)

A review on plants and herbal components with antiarrhythmic activities and their interaction with current cardiac drugs
由: Ahmad Beik, et al.
出版: (2020-05-01)

An algorithm for the selection of antiarrhythmic drugs for clinical pharmacologist
由: A. A. Upnitskiy
出版: (2014-12-01)

Antiarrhythmic Drug Dosing in Children—Review of the Literature
由: Nathalie Oeffl, et al.
出版: (2023-05-01)

Letter to the editor—Opinion on article by Rodriguez-Alvarez F et al.
由: Santiago Rodríguez Villafuerte, et al.
出版: (2025-01-01)

A Letter to the Editor on the Article by Farnam et al.—Author's Response
由: Farnam Farnaz, PhD, et al.
出版: (2015-09-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
由: IRAJ NAZERY , et al.
出版: (1986-12-01)

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES)
由: IRAJ NAZERY, et al.
出版: (1986-05-01)

Letter to the Editor regarding article Health effects of voluntary exposure to cold water – a continuing subject of debate, by Espeland, et al
由: Richard A. Reinhart
出版: (2023-12-01)

Historical Aspects of the Use of Antiarrhythmic Drugs in Clinical Practice
由: V. L. Doshchitsin, et al.
出版: (2022-07-01)

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
由: B. A. Tatarsky, et al.
出版: (2021-08-01)

Antiarrhythmic Drug Use in Pregnancy: Considerations and Safety Profiles
由: Marco Valerio Mariani, et al.
出版: (2024-08-01)

Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
由: Sean P. Gaine, et al.
出版: (2023-04-01)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
由: Gheorghe-Andrei Dan, et al.
出版: (2018-12-01)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
由: Ibrahim El-Battrawy, et al.
出版: (2019-08-01)

Electrophysiological Effects of a New Antiarrhythmic Drug Aksaritmin
由: Ravshanbek D. Kurbanov, et al.
出版: (2019-06-01)

Impact of Antiarrhythmic Drugs on Complex Fractionated Atrial Electrograms
由: Koichiro Kumagai, MD, et al.
出版: (2011-01-01)

Initiation and outcomes with Class Ic antiarrhythmic drug therapy
由: Xu Gao, et al.
出版: (2018-03-01)

Letter to the Editor in regard to the “Effects of COVID-19 on in-hospital cardiac arrest: incidence, causes, and outcome” by Roedl et al.”
由: A. D. Krieg, et al.
出版: (2021-11-01)

Response to letter by Campbell et al. regarding the results of the COSTICK trial
由: Andrew Smyth, et al.
出版: (2023-07-01)

Reply letter to “response to article by Johnna Perdrizet et al.” by Gomez and colleagues
由: Johnna Perdrizet, et al.
出版: (2022-01-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
由: K. A. Skiba, et al.
出版: (2003-06-01)

A letter to the editor regarding the original article by Costa et al: Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria
由: Biggs, M
出版: (2019)

Letter to the Editor regarding article “Electrocardiographic markers of increased risk of sudden cardiac death in patients with COVID‐19 pneumonia”
由: Fenglin Jiang
出版: (2021-07-01)

Response by Shimura et al. to the letter regarding article “Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement”
由: Tetsuro Shimura, et al.
出版: (2021-08-01)